Graph not available
Graph not available

Open Demat Account

50years
50 Years
of Trust & Legacy
₹0 AMC
for First Year
₹0 Brokerage
on Delivery, Intraday, Currency and NSE F&O
left-arrow
Fundamentals
Financials
Shareholding
Resistance/Support
Delivery and Volume
About
Management
News
Similar Stocks
right-arrow

Omkar Pharmachem Ltd Fundamentals

Market Cap
₹ 22.14 Cr
P/E Ratio (TTM)
109.75
P/B Ratio
2.41
Debt to Equity
0.09
ROE
1.98
EPS (TTM)
0.20
Dividend Yield
0.00 %
Book Value
9.11

Click here to know more about Fundamentals

Omkar Pharmachem Ltd Financials

Omkar Pharmachem Ltd Financials

Omkar Pharmachem Ltd Shareholding Pattern

Held By Mar 2024 Dec 2023 Sep 2023 Jun 2023
Retail 98.36 % 98.36 % 98.36 % 98.37 %
Others 1.61 % 1.61 % 1.61 % 1.60 %
Promoters 0.03 % 0.03 % 0.03 % 0.03 %
Mutual Funds 0.00 % 0.00 % 0.00 % 0.00 %
FII 0.00 % 0.00 % 0.00 % 0.00 %

Retail

98.36%

Others

1.61%

Promoters

0.03%

Mutual Funds

0.00%

FII

0.00%

Retail

98.36%

Others

1.61%

Promoters

0.03%

Mutual Funds

0.00%

FII

0.00%

Retail

98.36%

Others

1.61%

Promoters

0.03%

Mutual Funds

0.00%

FII

0.00%

Retail

98.37%

Others

1.60%

Promoters

0.03%

Mutual Funds

0.00%

FII

0.00%

Resistance and Support

₹21.95

PIVOT

resistance-arrow
Resistance
First Resistance₹21.950
Second Resistance₹21.950
Third Resistance₹21.950
support-arrow
Support
First Support₹21.950
Second Support₹21.950
Third Support₹21.950

Delivery and Volume

PeriodDelivery Volume Traded Volume Delivery Volume %
Day1010100.00
Week10370.00
1 Month10630.00
6 Months979979100.00

About Omkar Pharmachem Ltd

Omkar Pharmachem Limited was incorporated in 31 March 1995. The company has not done any commercial activity during the year. At present, it is incorporated with the object of doing business of pharmaceuticals and chemical product.

Managing Director

1995

Founded

Bhawani Shankar Goyal

NSE Symbol

NA

Omkar Pharmachem Ltd Management

NameDesignation
Parminder SharmaNon Executive Director
Mamta PachoriIndependent Director
Janak RajIndependent Director
Pankaj SinghCompany Sec. & Compli. Officer
Bhawani Shankar GoyalManaging Director

Omkar Pharmachem Ltd News

Omkar Pharmachem to discuss results
On 14 February 2024
Omkar Pharmachem standalone net profit rises 12.50% in the September 2023 quarter
Reported sales nil
Omkar Pharmachem schedules board meeting
On 10 November 2023
Omkar Pharmachem to hold AGM
On 29 September 2023
Omkar Pharmachem reports standalone net profit of Rs 0.05 crore in the June 2023 quarter
Reported sales nil
Omkar Pharmachem to convene board meeting
On 14 August 2023
Omkar Pharmachem reports standalone net loss of Rs 0.01 crore in the March 2023 quarter
Reported sales nil
Omkar Pharmachem to discuss results
On 30 May 2023
Omkar Pharmachem schedules board meeting
On 30 May 2023
Omkar Pharmachem reports standalone net profit of Rs 0.08 crore in the December 2022 quarter
Reported sales nil

Similar Stocks

CompanyMarket CapMarket PriceP/E Ratio
Central Depository Services (India) Ltd₹ 22660.3 Cr
₹ 2,168.45
(0.17 %)
62.37
TBO Tek Ltd₹ 15370.6 Cr
₹ 1,415.50
(1.43 %)
297.09
Indegene Ltd₹ 12765 Cr
₹ 533.50
(1.78 %)
98.12
RattanIndia Enterprises Ltd₹ 10546.72 Cr
₹ 76.30
(-0.13 %)
22.08
Godrej Agrovet Ltd₹ 10522.31 Cr
₹ 547.35
(-0.72 %)
29.48

Omkar Pharmachem Ltd FAQ

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Omkar Pharmachem Ltd shares in BlinkX

Omkar Pharmachem Ltd's P/E ratio is 109.75 times as of May 16, 2024 at 04:00 PM.

Omkar Pharmachem Ltd's most recent financial reports indicate a price-to-book ratio of 2.41, showing the company's stock market valuation in relation to the value of its real assets.

Market capitalisation, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Omkar Pharmachem Ltd's market is 22 Cr as on May 16, 2024 at 04:00 PM.

The current financial records of Omkar Pharmachem Ltd show a 1.98% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

According to Omkar Pharmachem Ltd's most recent financial filings, the company has a total asset value of Crores, which includes current and non-current assets such as inventory, cash, properties, and equipment.

As of the Mar 2024 quarter, the promoter shareholding in Omkar Pharmachem Ltd stands at 0.03%. During the same period, Institutional Investors have shown a slight values are equal in their holdings, values are equal from 0.00% to 0.00%.